- Home
- MRNA vs EHC Comparison
MRNA vs EHC Comparison
Compare MRNA & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- EHC
- Stock Information
- Founded
- MRNA 2010
- EHC 1983
- Country
- MRNA United States
- EHC United States
- Employees
- MRNA N/A
- EHC N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- EHC Hospital/Nursing Management
- Sector
- MRNA Health Care
- EHC Health Care
- Exchange
- MRNA Nasdaq
- EHC Nasdaq
- Market Cap
- MRNA 13.4B
- EHC 12.3B
- IPO Year
- MRNA 2018
- EHC 1986
- Fundamental
- Price
- MRNA $28.02
- EHC $120.35
- Analyst Decision
- MRNA Hold
- EHC Strong Buy
- Analyst Count
- MRNA 20
- EHC 6
- Target Price
- MRNA $46.24
- EHC $132.83
- AVG Volume (30 Days)
- MRNA 8.6M
- EHC 942.9K
- Earning Date
- MRNA 08-01-2025
- EHC 08-04-2025
- Dividend Yield
- MRNA N/A
- EHC 0.63%
- EPS Growth
- MRNA N/A
- EHC 30.39
- EPS
- MRNA N/A
- EHC 5.11
- Revenue
- MRNA $3,078,000,000.00
- EHC $5,669,100,000.00
- Revenue This Year
- MRNA N/A
- EHC $10.75
- Revenue Next Year
- MRNA $10.04
- EHC $8.59
- P/E Ratio
- MRNA N/A
- EHC $23.48
- Revenue Growth
- MRNA N/A
- EHC 11.80
- 52 Week Low
- MRNA $23.15
- EHC $87.36
- 52 Week High
- MRNA $91.99
- EHC $123.13
- Technical
- Relative Strength Index (RSI)
- MRNA 46.33
- EHC 67.54
- Support Level
- MRNA $25.30
- EHC $116.90
- Resistance Level
- MRNA $27.08
- EHC $118.48
- Average True Range (ATR)
- MRNA 1.33
- EHC 2.42
- MACD
- MRNA -0.31
- EHC 1.30
- Stochastic Oscillator
- MRNA 32.38
- EHC 97.29
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.